Regulation of osteoclast protease expression by RANKL.

Biochem Biophys Res Commun

Laboratoire de Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives EE 99-01, Faculté de Médecine, Nantes, France.

Published: October 2003

Receptor activator of NF-kappaB ligand (RANKL) is essential for osteoclast (OC) differentiation/activation and functions through its receptor RANK at the surface of the osteoclastic cells. This study investigated for the first time the direct effects of hRANKL on protease/protease inhibitor expressions and protease activities in purified rabbit osteoclast cultures, using semi-quantitative RT-PCR, gelatin zymography, and enzymatic assays. RANKL was shown to exert in vitro pro-resorptive effects by increasing osteoclast marker expressions (Tartrate resistant acid phosphatase (TRAP) and cathepsin K), MMP-9 expression, and pro-MMP-9 activity and by diminishing TIMP-1 expression, leading to an up-regulation of the MMP-9/TIMP-1 ratio.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2003.09.084DOI Listing

Publication Analysis

Top Keywords

regulation osteoclast
4
osteoclast protease
4
protease expression
4
expression rankl
4
rankl receptor
4
receptor activator
4
activator nf-kappab
4
nf-kappab ligand
4
ligand rankl
4
rankl essential
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!